IPO registrations (S-1, F-1) · Registrants
KOSAN BIOSCIENCES INC
- SEC CIK
- 1110206 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-03-31, last 2000-10-04; 1 initial registration, 4 amendments
- Outcome
- Final prospectus filed 2000-10-05
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- CA
- Business address
- 3832 BAY CENTER PLACE, Hayward, CA 94545
- EIN
- 94-3217016
- EDGAR entity type
- operating
- Insiders and CEO pay
- KOSAN BIOSCIENCES INC on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2000-10-04)
- Final price
- $14.00 per share, within the range (424B4 filed 2000-10-05, an initial public offering)
- Shares sold
- 5,000,000
- Gross proceeds
- $70,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol KOSN
- Lead underwriters
- Lehman Brothers; CIBC World Markets (1,059,250 shares); Cowen (1,059,250 shares); Services LLC (60,000 shares)
- Syndicate
- Fidelity Capital Markets; J.P. Morgan (60,000); A.G. Edwards (60,000); ING Barings LLC (60,000); Lazard (60,000); Prudential Securities (60,000); Fahnestock & Co. Inc (49,000); Edwards D. Jones & Co., L.P (49,000); Raymond James (49,000); Ragen Mackenzie Incorporated (49,000); Wm. Smith Securities, Incorporated (49,000); UBS (49,000); Wachovia (49,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: KOSAN BIOSCIENCES INC EXACT (CIK (EXACT))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-03-31 | S-1 | S-1 (registration) | KOSAN BIOSCIENCES INC | 0000912057-00-015627 ↗ |
| 2000-08-08 | S-1/A | S-1/A (amendment) | KOSAN BIOSCIENCES INC | 0000912057-00-035223 ↗ |
| 2000-09-07 | S-1/A | S-1/A (amendment) | KOSAN BIOSCIENCES INC | 0000912057-00-040472 ↗ |
| 2000-09-28 | S-1/A | S-1/A (amendment) | KOSAN BIOSCIENCES INC | 0000912057-00-043026 ↗ |
| 2000-10-04 | S-1/A | S-1/A (amendment) | KOSAN BIOSCIENCES INC | 0000912057-00-043784 ↗ |
| 2000-10-05 | 424B4 | 424B4 (final prospectus) | KOSAN BIOSCIENCES INC | 0000912057-00-043836 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-10-04 | S-1/A | registration statement | $14.00–$16.00 | 5,000,000 | - | Nasdaq KOSN | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2000-10-05 | 424B4 | final prospectus | $14.00 | 5,000,000 | $70,000,000 | Nasdaq KOSN | 17 | primary document; price sentence, shares headline, proceeds table, underwriting table 15, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| SANTI DANIEL V MD PHD | Director,Officer,TenPercentOwner; TenPercentOwner | Chairman and CEO; Chariman and CEO | 14 | 2006 | |
| Horn Margaret A | Officer | SVP, General Counsel | 2 | 2006–2007 | |
| Johnson David Louis | Officer | Prin Acct Off & Prin Fin Off | 1 | 2006 | |
| KHOSLA CHAITAN PHD | Director | 10 | 2006–2008 | ||
| JOHNSON ROBERT G JR MD PHD | Director; Director,Officer; Officer | CEO; President and CEO | 7 | 2006–2008 | |
| Licari Peter | Officer | SVP Manufacturing & Operations | 8 | 2006–2008 | |
| Timmermans Pieter B | Officer | SVP Drug Disc & Preclin Dev | 6 | 2006–2008 | |
| DELEAGE JEAN | Director | 7 | 2006–2008 | ||
| CHABNER BRUCE A MD | Director | 6 | 2006–2008 | ||
| Clemens Kevan | Director | 7 | 2006–2008 | ||
| DAVIS PETER PHD | Director; Director,Officer | President and CEO | 10 | 2006–2008 | |
| HOMCY CHARLES J | Director | 2 | 2006–2007 | ||
| WALSH CHRISTOPHER T PHD | Director | 5 | 2006–2008 | ||
| Titus Gary | Officer | Sr. VP and CFO | 9 | 2006–2008 | |
| De Jager Robert | Officer | SVP, Chief Medical Officer | 2 | 2006 | |
| Wright Jonathan K. | Officer | Sr. V.P. and General Counsel; SVP and General Counsel | 6 | 2007–2008 | |
| Kim Helen Susan | Officer | President and CEO; President, CBO; Sr VP, Chief Business Officer | 5 | 2008 | |
| Cohen Pamela Sarah | Officer | Chief Medical Officer | 3 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | KOSAN BIOSCIENCES INC | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, CA first:
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- SIGNAL PHARMACEUTICALS INC CA
- DELTAGEN INC CA
- MAXYGEN INC CA
- CytoCore, Inc. CA
- diaDexus, Inc. (pre-merger) CA
- SENOMYX INC CA
- DNA SCIENCES INC CA
- KINEMED INC CA
In other datasets, the same topic (Medical research) in CA:
- Nonprofit: 23ANDME RESEARCH INSTITUTE (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research